The Feiba VH market is witnessing steady growth over the forecast period, supported by growth in personalized hemophilia management, expanding access to specialty hemophilia centers.
Read More
The Feiba NF market is witnessing steady growth over the forecast period, supported by rising hemophilia diagnosis rates, expansion of home infusion programs.
Read More
The Fabrazyme market is witnessing steady growth over the forecast period, supported by rising awareness of fabry disease, improved genetic screening programs.
Read More
The Eylea HD market is witnessing steady growth over the forecast period, supported by rising diabetic retinopathy cases, demand for long acting formulations.
Read More
The Extavia market is witnessing steady growth over the forecast period, supported by increasing ms diagnosis rates, growth in combination therapy approaches.
Read More
The Exondys 51 market is witnessing steady growth over the forecast period, supported by advancements in molecular genetics, expansion of personalized neuromuscular care.
Read More
The Evkeeza market is witnessing steady growth over the forecast period, supported by increasing genetic screening for lipid disorders, rising adoption of biologics.
Read More
The Evithrom market is witnessing steady growth over the forecast period, supported by growth in surgical interventions, rising accident and trauma rates.
Read More
The Evicel market is witnessing steady growth over the forecast period, supported by growth in minimally invasive surgeries, rising surgical volumes.
Read More
The Evenity market is witnessing steady growth over the forecast period, supported by growing awareness of bone health, increasing osteoporosis screening.
Read More